Stephanie Tagliatela

Stephanie Tagliatela is a co-founder and chief scientific officer at Encoded Therapeutics Inc., where Stephanie has been integral since June 2014. Prior experience includes serving as a PhD graduate student researcher in the Molecular and Cellular Neuroscience Program at the Massachusetts Institute of Technology from 2012 to 2014, and as a research assistant at Wesleyan University from June 2010 to June 2012, as well as a research assistant at Yale University in the summer of 2009. Stephanie obtained a Bachelor of Arts in Biological and Biomedical Sciences from Mount Holyoke College in 2010.